Effect of Dietary Purines on the Pharmacokinetics of Orally Administered Ribavirin
- 1 June 2009
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 49 (6), 661-667
- https://doi.org/10.1177/0091270009335002
Abstract
Ribavirin is found to be absorbed in the intestine through the human concentrative nucleoside transporter 2 (hCNT2). Cellular uptake of ribavirin was strongly inhibited by purine nucleoside in an in vitro study. This study aims to examine the effects of dietary purine on the pharmacokinetics of orally administered ribavirin in vivo. Twenty healthy participants were enrolled in a randomized, 2-period crossover study. Participants were administered a single 600-mg oral dose of ribavirin after either a high-purine meal or a low-purine meal. Serial blood samples were collected predose and over 144 hours after dosing. Ribavirin concentrations were measured by liquid chromatography/tandem mass spectrometry. In comparison with corresponding plasma values of ribavirin following a high-purine meal, C(max), AUC(0-144) and AUC(0-infinity) of ribavirin following a low-purine meal were 136% (90% confidence internal [CI]: 120%-155%), 134% (90% CI: 118%-153%), and 139% (90% CI: 120%-159%), respectively. This study indicates that dietary purines have an effect on ribavirin absorption. Dosage regimens of ribavirin might need to be adjusted according to the purine content of the meal.Keywords
This publication has 15 references indexed in Scilit:
- Absence of Clinically Relevant Pharmacokinetic Interaction Between Ribavirin and Tenofovir in Healthy SubjectsThe Journal of Clinical Pharmacology, 2006
- High-dose ribavirin in combination with standard dose peginterferon for treatment of patients with chronic hepatitis CJournal of Hepatology, 2005
- Differences in treatment outcome for hepatitis C among ethnic groupsThe American Journal of Medicine, 2004
- Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis CAnnals of Internal Medicine, 2004
- The concentrative nucleoside transporter family, SLC28Pflügers Archiv - European Journal of Physiology, 2004
- Southeast Asian patients with chronic hepatitis C: The impact of novel genotypes and race on treatment outcomeJournal of Hepatology, 2002
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus InfectionThe New England Journal of Medicine, 2002
- Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Na+/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridineMolecular Membrane Biology, 1998
- Intestinal Absorption of Ribavirin Is Preferentially Mediated by the Na+-Nucleoside Purine (Nl) TransporterPharmaceutical Research, 1998
- Ribavirin disposition in high-risk patients for acquired immunodeficiency syndromeClinical Pharmacology & Therapeutics, 1987